bimekizumab
AS0014
Phase 3 small_molecule active
Quick answer
bimekizumab for Axial Spondyloarthritis is a Phase 3 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Axial Spondyloarthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active